Brainstorm Cell Therapeutics Inc. (BCLI)

CIK 1137883 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Brainstorm Cell Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001104659-26-097275
Aug 14, 20268-K0001104659-26-097180
Jul 30, 20268-K0001104659-26-088728
Jul 28, 202640001104659-26-087588
Jul 28, 202640001104659-26-087584
Jun 3, 202630001104659-26-070209
Jun 2, 2026EFFECT9999999995-26-001853
May 29, 202640001104659-26-068337
May 29, 202640001104659-26-068339
May 29, 202640001104659-26-068338
May 29, 202640001104659-26-068336
May 29, 202640001104659-26-068335
May 28, 20268-K0001104659-26-067474
May 21, 2026S-10001104659-26-064628
May 21, 2026S-80001104659-26-064632
May 20, 202640001104659-26-064652
May 20, 202640001104659-26-064656
May 20, 202640001104659-26-064657
May 20, 202640001104659-26-064653
May 20, 202640001104659-26-064650
May 20, 202640001104659-26-064658
May 15, 20268-K0001104659-26-062766
May 15, 202610-Q0001104659-26-062648
Mar 31, 202610-K0001104659-26-037927
Mar 31, 20268-K0001104659-26-037760